United Kingdom-based GW Pharmaceuticals expects to report annual sales of roughly $526 million for the year ended Dec. 31, 2020, the company said in a preview of its fourth quarter and full-year results. Fourth-quarter net sales will be approximately $148 million, based on preliminary unaudited financial information, GW said. Epidiolex, the company’s most successful product, […]
GW Pharma expects fiscal 2020 sales to reach $526 million is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs